The TCTN2 gene helps build and maintain tiny cell antennas called cilia, which guide early development of the brain, face, and limbs. If it does not work properly, these signals can be disrupted, and a child may be born with a condition affecting brain development, facial features, breathing, or extra fingers or toes. The protein made by this gene helps your cells coordinate the growth signals that shape the body before birth.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or guide processes in the body. Some genes hold the code for proteins, the parts of cells that do the work. Other genes mostly help regulate when certain processes happen, where they happen, and how strongly they are carried out. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
TCTN2Gene function
What if the gene works
The TCTN2 gene helps build and organize primary cilia, tiny cell structures that act like antennae. By supporting signaling through these cilia, it helps guide early development of the brain, face, and other organs.
Risk
What if the gene does not work
More disruptive variants in the TCTN2 gene can cause a ciliopathy, often affecting brain development, breathing control, and movement, and sometimes the kidneys, liver, or extra fingers and toes. Milder variants may lead to a less severe pattern.
Treatment
What does that mean for your treatment
No TCTN2-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the TCTN2 gene.
Conditions associated with TCTN2
Gene function
What if the gene works
Many cells use a tiny antenna-like structure to sense signals from their surroundings. The TCTN2 gene helps organize a key area at the base of this structure, where materials move in and out. It also supports signaling that guides early body development. Understanding what the TCTN2 gene does in early development helps explain how cells coordinate growth and patterning before birth.
The TCTN2 gene helps build and stabilize the gateway at the base of the primary cilium, a tiny cell antenna. This gateway helps control which proteins enter and leave so the cilium can work in an orderly way.
Inside this cell antenna, the TCTN2 gene supports pathways that tell cells when to grow, move, or take on specific roles. One important pathway is Hedgehog signaling, a system cells use to share growth and patterning instructions.
During early development, the TCTN2 gene helps cells respond to signals that lay out the body's plan. This supports the forming brain, face, limbs, and other structures in the right place at the right time.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TCTN2 gene can change the shape, stability, or placement of the TCTN2 protein at the base of the cell’s cilium, which can weaken key protein-to-protein contacts and disrupt signaling. In explaining how TCTN2 gene variants affect cells, milder variants may leave some protein activity intact, while more severe variants can sharply reduce or abolish it. This severity range often influences how strongly cilia-related developmental pathways are disturbed and, in established TCTN2-related conditions, can affect how early and how broadly features appear.
How variants are linked to conditions
Pathogenic variants in the TCTN2 gene can cause Joubert syndrome and Meckel syndrome, two rare inherited conditions present from early development. In people with a TCTN2-related diagnosis, findings may include differences in brain development, low muscle tone, unusual breathing or eye movements, and, in Meckel syndrome, changes affecting the kidneys, liver, or skull. Some variants in the TCTN2 gene are also reported in closely related ciliopathy conditions.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the TCTN2 gene. For families with a known TCTN2 change, risk mainly depends on whether a child inherits gene changes from both parents, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of TCTN2 variants
TCTN2 gene variants linked to known TCTN2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one changed copy of the TCTN2 gene from each parent. When both parents carry one variant, each pregnancy has a 25% chance of the child having the condition, a 50% chance of the child being a carrier, and a 25% chance of inheriting neither changed copy. Parents who are carriers usually do not have symptoms.
What does my TCTN2 result mean for my family?
For TCTN2, the best-known related conditions are inherited in a recessive pattern, which means close relatives may also carry the same gene change without having symptoms. Brothers and sisters could be affected or could be carriers, and other family members may also carry the variant. For future children, the family implications depend on whether both biological parents carry a TCTN2 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for TCTN2 variants usually uses a blood or saliva sample to read the TCTN2 gene and check for changes linked to certain inherited conditions. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance, which means the change has not yet been clearly understood.
When should I consider getting a genetic test?
Consider TCTN2 testing if a baby, child, or pregnancy shows signs of a rare inherited condition with major brain or face differences, extra fingers or toes, or kidney problems, or if a close relative has a known TCTN2 change. It can also help clarify carrier status when these conditions run in a family.
A genetic result is only one part of your health story
A genetic result can provide meaningful insight, although what it reveals depends on the condition and the type of variant involved. Over time, many influences, including lifestyle, environment, age, and medical history, shape how the body functions. For some conditions, especially those affected by many genes, genetic information adds context rather than certainty and is best understood alongside other aspects of care. In other cases, a genetic result can provide a clear answer. In areas such as medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, which helps explain why the same treatment works well for one person but less well for another. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. These common differences can influence how much benefit a medicine gives and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It looks at gene-drug patterns to help explain why treatments work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body processes it. This information can support more informed and individualized treatment decisions. More on this topic can be found in the LearnHub.
Drugs influenced by the TCTN2 gene
When should I seek medical advice?
There is not currently a broadly confirmed role for this gene in guiding how medicines are chosen or used. If you have concerns about side effects, how well a treatment is working, or possible medicine interactions, talk with your doctor or pharmacist.
History
TCTN2 entered medical genetics through research on rare inherited conditions that affect early development. Initially understood only through visible traits, later recognized as tied to a specific gene, it was identified as part of a broader group of genes linked to ciliopathies, a family of conditions caused by changes in tiny cell structures called cilia. From these first observations, research expanded steadily as sequencing studies connected TCTN2 variants with Joubert syndrome and Meckel syndrome in some families. Over time, descriptions became more precise as clinicians and researchers compared genetic findings with patterns seen on brain scans and physical exams. These historical steps shaped today’s understanding of TCTN2 in developmental genetics.